SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 5.74% in the revenue at Rs. 36306.00 millions was reported in the June 2022 quarter as compared to Rs. 34335.00 millions during year-ago period.A humble growth in net profit of 20.83% reported in the quarter ended June 2022 to Rs. 4995.00  millions from Rs. 4134.00 millions.OP of the company witnessed a marginal growth to 9829.00 millions from 7481.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 36306.00 34335.00 5.74 36306.00 34335.00 5.74 144052.00 133491.00 7.91
Other Income 4034.00 1862.00 116.65 4034.00 1862.00 116.65 4820.00 8011.00 -39.83
PBIDT 9829.00 7481.00 31.39 9829.00 7481.00 31.39 30761.00 39379.00 -21.88
Interest 98.00 65.00 50.77 98.00 65.00 50.77 380.00 467.00 -18.63
PBDT 9731.00 7416.00 31.22 9731.00 7416.00 31.22 30381.00 38912.00 -21.92
Depreciation 2215.00 1971.00 12.38 2215.00 1971.00 12.38 8143.00 8350.00 -2.48
PBT 7516.00 5445.00 38.03 7516.00 5445.00 38.03 22238.00 30562.00 -27.24
TAX 2521.00 1311.00 92.30 2521.00 1311.00 92.30 6006.00 8698.00 -30.95
Deferred Tax 1163.00 327.00 255.66 1163.00 327.00 255.66 2080.00 3297.00 -36.91
PAT 4995.00 4134.00 20.83 4995.00 4134.00 20.83 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 27.07 21.79 24.25 27.07 21.79 24.25 21.35 29.50 -27.61

Dr. Reddys Labs. Share Price

1350.00 21.65 (1.63%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: